Disease modifying drugs in adult rheumatoid arthritis

Australian Prescriber

Volumn 26, Issue 2, 2003, Pages 36-40

  Lee, Anita T Y ^a   Pile, Kevin ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Leflunomide; Methotrexate; Sulfasalazine

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; ETANERCEPT; FOLIC ACID ANTAGONIST; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; SALAZOSULFAPYRIDINE; SALICYLIC ACID; TOLBUTAMIDE; TRIMETHOPRIM; WARFARIN;

ABDOMINAL PAIN; ALCOHOL CONSUMPTION; ALLERGIC PNEUMONITIS; ALOPECIA; ANOREXIA; BONE MARROW SUPPRESSION; BREAST FEEDING; CONGENITAL MALFORMATION; DEPRESSION; DIARRHEA; DISABILITY; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; EXERCISE; FOLIC ACID DEFICIENCY; GASTROINTESTINAL SYMPTOM; GROWTH RETARDATION; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; JOINT DEGENERATION; LABORATORY TEST; LEUKOPENIA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER TOXICITY; LUNG INFILTRATE; MOUTH ULCER; MUCOSA; NAUSEA; NEUTROPENIA; OCCUPATIONAL THERAPY; OLIGOSPERMIA; PATIENT MONITORING; PHYSIOTHERAPY; POLYARTHRITIS; PRACTICE GUIDELINE; PREGNANCY; PRURITUS; PSORIASIS; RASH; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SIDE EFFECT; SPERMATOZOON MOTILITY; TERATOGENICITY; VERTIGO; VOMITING;

EID: 0037249142     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2003.028     Document Type: Review

References (6)

1. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
2. O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91. (randomised trial)
3. Methotrexate - name the day. Aust Adv Drug React Bull 1998;17:3.
4. Kanagarajah S. Perils and pitfalls of methotrexate prescription. Aust Prescr 2000;23:44-5.
5. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623-9.
6. Klippel JH. Biologic therapy for rheumatoid arthritis [letter] [published erratum appears in N Engl J Med 2001;344:76]. N Engl J Med 2000;343:1640-1.